Organon & Co. (OGN)

USD 9.59

(1.48%)

Net Debt Summary of Organon & Co.

  • Organon & Co.'s latest annual net debt in 2023 was 8.06 Billion USD , down -1.71% from previous year.
  • Organon & Co.'s latest quarterly net debt in 2024 Q2 was 7.95 Billion USD , down -2.3% from previous quarter.
  • Organon & Co. reported annual net debt of 8.2 Billion USD in 2022, down -2.26% from previous year.
  • Organon & Co. reported annual net debt of 8.39 Billion USD in 2021, up 1890.41% from previous year.
  • Organon & Co. reported quarterly net debt of 7.98 Million USD for 2024 Q3, up 0.43% from previous quarter.
  • Organon & Co. reported quarterly net debt of 7.95 Billion USD for 2024 Q2, down -2.3% from previous quarter.

Annual Net Debt Chart of Organon & Co. (2023 - 2018)

Historical Annual Net Debt of Organon & Co. (2023 - 2018)

Year Net Debt Net Debt Growth
2023 8.06 Billion USD -1.71%
2022 8.2 Billion USD -2.26%
2021 8.39 Billion USD 1890.41%
2020 -469 Million USD -118.14%
2019 -215 Million USD -126.32%
2018 -95 Million USD 0.0%

Peer Net Debt Comparison of Organon & Co.

Name Net Debt Net Debt Difference
AbbVie Inc. 46.57 Billion USD 82.678%
Bristol-Myers Squibb Company 30 Billion USD 73.11%
Bristol-Myers Squibb Company Ce 30 Billion USD 73.11%
Johnson & Johnson 7.47 Billion USD -7.949%
Eli Lilly and Company 22.4 Billion USD 63.997%
Merck & Co., Inc. 29.35 Billion USD 72.523%
Novartis AG 12.95 Billion USD 37.731%
Pfizer Inc. 72.18 Billion USD 88.825%